Actos Bladder Cancer Update

California Actos Attorney

Concerned Actos users should be aware of the latest news concerning the pending litigation.

Following an FDA safety warning issued in June 2011, a number of Actos users have filed injury claims against the drug’s manufacturer Takeda Pharmaceuticals, alleging that the popular Type 2 diabetes medication caused serious complications, including bladder cancer. Nadrich & Cohen, LLP is committed to providing concerned Actos users with the latest news and updates on the pending litigation and the continued sale of the drug.

Latest Actos Side Effects Lawsuit News:

Consolidation of Federal Actos Cases

On December 28, 2011, a U.S. Judicial Panel on Multidistrict Litigation voted to consolidate all pending federal Actos lawsuits into a single multidistrict litigation (MDL) for pretrial proceedings. The cases were transferred to the U.S. District Court for the Western District of Louisiana  with the Honorable Rebecca F. Doherty presiding. In all, approximately 100 lawsuits were centralized in the Louisiana MDL, which was approved after numerous plaintiffs filed a motion to have the cases consolidated in order to streamline the proceedings and reduce costs for all parties involved.

Class Action Actos Lawsuit Filed in Canada

A class action Actos side effects lawsuit was filed in Ontario, Canada in December 2011 on behalf of numerous patients who say they suffered serious side effects after taking the drug. The class action suit, which also names Eli Lilly as a co-defendant, alleges that both companies knew of the drug’s bladder cancer risk but did not take adequate steps to warn the public of the potential risks.

European Commission Concludes Actos Safety Review

In January 2012, the European Commission concluded its months-long safety review of Actos. The Commission concluded that the drug could continue to be sold in Europe to treat adult patients with Type 2 diabetes, despite the potential bladder cancer risk. This move supported an earlier announcement by the European Medicines Agency that Actos should still be considered a viable treatment for diabetes patients for whom other medications or treatments would be ineffective.

New Actos bladder cancer lawsuits are being filed against Japanese drug-maker Takeda Pharmaceuticals. Most recently, an Edwardsville, Illinois man filed a claim alleging that he was diagnosed with bladder cancer after taking Actos and that had he known of the drug’s risks, he would not have taken the medication. If you or a loved one has been diagnosed with bladder cancer or experienced another serious complication after taking Actos, you need to understand your legal rights.

The experienced personal injury attorneys at Nadrich & Cohen, LLP are currently investigating Actos bladder cancer claims in all 50 states and we want to hear from you. Call our Injury Hotline today at 1-800-722-0765 to schedule your no-cost, no-obligation initial case evaluation. All cases are accepted on a contingency basis, meaning there is never a fee unless we recover damages on your behalf.

The Nadrich & Cohen personal injury blogs are sponsored by Nadrich & Cohen, LLC. This blog features news stories, personal cases and analysis of current events, all of which are intended for illustrative purposes only. Each case is different, and legal authority is constantly changing and evolving. Therefore, nothing on this site should be viewed as a guarantee or prediction of a similar future outcome. The information on this site should not be treated as authoritative, and readers should always consult with legal counsel before making any important legal decisions. Lastly, Nadrich & Cohen, LLC is not responsible for any comments contributed by visitors to this website.

Tags: , , , , , , , , , ,

One Response to “Actos Bladder Cancer Update”

  1. Heather Sherman
    14. Feb, 2012 at 9:15 am #

    Wohh precisely what I was searching for, thanks for posting.

Leave a Reply

Name (required)

Email (will not be published) (required)